Browse by category

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are cost effective in the long term only when combined with bariatric surgery,...

Introducing RefluxStop device (Implantica) as a treatment option for gastroesophageal reflux disease (GERD) patients treated within the...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

An economic evaluation comparing endoscopic sleeve gastroplasty (ESG) with semaglutide for treating class II obesity has suggested ESG is...

A new USC Schaeffer Center white paper finds the value to society of Medicare coverage for new classes of weight loss drugs would equal...

A study that compared expenditures for diabetes medications before and after metabolic surgery among patients with diabetes in Michigan...

The Institute for Clinical and Economic Review (ICER) in the US has published its revised Evidence Report assessing the comparative...

Roux-en-Y gastric bypass (RYGB) leads to greater weight loss and a greater rate of remission of diabetes than sleeve gastrectomy or...